This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07128/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07128/identifier/pubchem-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07128/identifier/pubchem-substance/
n5http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB07128/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07128/identifier/chemspider/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07128
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n5:DB07128 n6:DB07128
dcterms:title
N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE
adms:identifier
n9:4449884 n10:DB07128 n11:99443599 n12:501 n13:5287523
n3:IUPAC-Name
n7:271B4CA6-363D-11E5-9242-09173F13E4C5
n3:InChI
n7:271B4CAC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n7:271B4CAB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n7:271B4CA8-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n7:271B4CA9-363D-11E5-9242-09173F13E4C5
n3:SMILES
n7:271B4CAA-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n7:271B4CA4-363D-11E5-9242-09173F13E4C5
n3:logP
n7:271B4CA2-363D-11E5-9242-09173F13E4C5 n7:271B4CA5-363D-11E5-9242-09173F13E4C5
n3:logS
n7:271B4CA3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n7:271B4CB2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n7:271B4CB3-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n7:271B4CAD-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n7:271B4CAE-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n7:271B4CB0-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n7:271B4CAF-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n7:271B4CB1-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n7:271B4CB8-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n7:271B4CBA-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n7:271B4CBB-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n7:271B4CB7-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n7:271B4CB6-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n7:271B4CB9-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n7:271B4CA7-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n7:271B4CB4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n7:271B4CB5-363D-11E5-9242-09173F13E4C5